Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

G_genetic testing New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of ...

Clinical practice guidelines do not recommend routine PSA screening in men older than 75 years, men younger than 40 years, or men with a life expectancy of <10 years; however, inappropriate PSA ...

Urologists had championed the prostate cancer test in the past It%27s a %22radical change%22 but a welcome one Risks of incontinence%2C impotence and infection are weighed In a major break from the ...

P4 Diagnostix has teamed with Pierian, a company that provides an analysis platform, to launch somatic testing for patients with prostate cancer. The partnership will further develop P4 Diagnostix’s ...

MDxHealth has 4 validated testing products with one more in the clinical pipeline. All are focused specifically on urology. The company expects to do ~$65-$70M of sales in 2023, but the valuation is a ...

BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, and Solaris Health, the nation’s leading ...

Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with Mediwatch for urodynamics diagnostic equipment and urology/pelvic floor clinical testing ...

In their recent study, Kerfoot and colleagues suggest that “prostatempathy”—the empathy felt by older male healthcare providers—could explain the significant association between inappropriate PSA ...